Pharmacovigilance

Pharmacovigilance is a process associated with the identification, collection, evaluation, study and prevention of adverse reactions and any other issues related to the safety and effectiveness of medicinal products.

The functioning of the pharmacovigilance system of TEKHNOPACK MANUFACTURE LIMITED occurs in strict compliance with international directives and Ukrainian legislation.

Timely identification and receipt of data on undesirable consequences of medicines use is of great importance for assessing the safety, effectiveness and benefit/risk ratio of medicines.

It is important for us to receive feedback from all subjects of the circulation of the medicinal product — patients, pharmacists, doctors and other healthcare professionals on obtaining information regarding the safety of the company’s medicinal products.

What is important to inform about:

• About adverse reactions that occur during medical use of the medicinal product
• About the lack of effectiveness of the medicinal product
• About cases of overdose of the medicinal product
• About cases of erroneous use of the medicinal product
• About cases of abuse/improper use of the medicinal product
• About the use of the medicinal product off-label
• About unexpected benefits, or any other important information about the use of the medicinal product, related or not related to an adverse reaction, namely:
• About use during pregnancy or lactation
• About cases of use in children
• Inappropriate use of the medicinal product
• Unexpected therapeutic effect of the medicinal product
• Consequences of exposure to the medicinal product during professional activity

If you would like to report an adverse reaction and/or lack of effectiveness of medicinal products from TEKHNOPAK MANUFACTURE LIMITED, please contact us in the way convenient for you:

Fill out the message form below or provide information by email or phone:

Telephone (around the clock): +38 099 021-35-89
Email: pharma@tekhnopakmanufacture.com

The report must contain the following minimum information:

• Name of the suspected medicinal product
• Description of the adverse reaction and/or information about lack of effectiveness
• Information about the patient who experienced the adverse reaction (full name/initials, age, gender and other important information)
• Contact details and information about the person making the report (doctor, patient, relative or patient representative)

All information you provide is confidential and not subject to disclosure.